ARCHIVES

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

This article is from The Cancer Letter archive.

Vol. 18 No. 40 | October 16, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

September 25, 2009

Study: Vismodegib Effective Where Surgery is Inappropriate

June 24, 2011

Professional Society Growth Obvious At Spring Meetings; AACR Looking To Broaden Its Base

June 5, 1987

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

NCI Intramural Budget And List Of Highest-Funded Branches, Laboratories

April 21, 1995

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998